Navigation Links
WuXi AppTec Bioanalytical Services Unit Receives GLP Certificate from OECD and EU
Date:8/23/2011

SHANGHAI, Aug. 23, 2011 /PRNewswire-Asia/ -- WuXi AppTec announced today that its Bioanalytical Services (BAS) unit had received a certificate of Good Laboratory Practice (GLP) from the Organization for Economic Cooperation and Development (OECD) and the European Union (EU).  

The certificate states that WuXi's BAS facility in Shanghai is able to carry out ADME (absorption, distribution, metabolism, and excretion) studies, toxicokinetic and pharmacokinetic studies, and hERG assay and biomarker studies with respect to OECD and EU principles of Good Laboratory Practice.  Award of the certificate followed a thorough review of the facility operations and records on May 9-11, 2011, by Belgian authorities.  

This represents WuXi's third successful audit of its bioanalytical lab by regulatory authorities.  The facility also passed a bioequivalence study inspection by the U.S. Food and Drug Administration (FDA) in March 2009 and an inspection by China's State Food and Drug Administration (SFDA) supporting the certification of WuXi's GLP toxicology operation in Suzhou.  The BAS laboratory is now certified by the SFDA and OECD to provide GLP-compliant support for nonclinical studies.  In addition, this laboratory is certified by the OECD to support clinical trials for small-molecule and biologics pharmacokinetics and biomarker analysis.

WuXi's Bioanalytical Services (BAS) was established in 2005.  BAS provides GLP-compliant services to analyze small-molecule drugs using liquid chromatography/mass spectroscopy and to measure biomarker/biologics and antibody immunogenicity using immunochemistry.  It is the only bioanalytical laboratory in China to have passed SFDA, OECD, and FDA GLP inspections.

"We are very pleased to have passed this OECD/EU inspection," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec.  "WuXi will continue to pursue the highest levels of quality and transparency to meet and exceed international requirements."

"As a GLP-compliant facility, BAS always treats quality and compliance as our highest priorities," commented Dr. Jinsong Xing, Vice President of BAS of WuXi AppTec.  "We maintain GLP readiness through continuous training, review of technology, and rigorous proficiency testing.  Our quality control team thoroughly reviews all data and closely monitors the facility for compliance on a daily basis."

About WuXi PharmaTech and WuXi AppTec

WuXi PharmaTech (NYSE: WX) is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States.  As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.  WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec.  For more information, please visit: http://www.wuxiapptec.com .

For more information, please contact:

WuXi PharmaTech (Cayman) Inc.

Ronald Aldridge (for investors)
Director of Investor Relations
Tel:   +1-201-585-2048
Email: ir@wuxiapptec.com

Stephanie Liu (for the media)
WuXi PharmaTech (Cayman) Inc.
Tel:   +86-21-5046-4362
Email: pr@wuxiapptec.com


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
2. Cetero Research Names Dr. Roger Hayes President of Bioanalytical Operations
3. QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India
4. MicroConstants Completes Installation of Latest LC/MS/MS Technology to Achieve Improved Sensitivity in Bioanalytical Method Development
5. PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011
6. PharmaNets Bioanalytical Laboratory Recognized by the Standards Council of Canada for Good Laboratory Practice Compliance
7. PharmaNet Names Dr. George Scott Vice President of Bioanalytical Services
8. West Pharmaceutical Services, Inc. Appoints New Director
9. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
10. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
11. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of ... Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ... ... at US$ 7,167.6 Mn in 2015, and is expected to ... of 5.6% from 2016 to 2024. The ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
(Date:4/21/2017)... ... 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD ... a benign bony lump located on the forehead usually attributed to a facial fracture. ... and pain. Dr. Shah has discovered an approach that is minimally invasive. He is ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility ... Hong Kong to support teaching, learning and research. It is also the largest research ... Hong Kong. , With an area of 620 square metres and more than ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway Management, the medical device ... highly regarded and well renowned Asian distributor, Discovery Sleep. The agreement ... Pillow Mask, and will stabilize and strengthen Airway’s presence with a dedicated, reputable ...
Breaking Medicine News(10 mins):